USP30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.720200E-01
Normal-vs-Stage2
2.932400E-01
Normal-vs-Stage3
1.423560E-02
Normal-vs-Stage4
5.232600E-01
Stage1-vs-Stage2
1.961640E-01
Stage1-vs-Stage3
1.293370E-01
Stage1-vs-Stage4
3.405800E-01
Stage2-vs-Stage3
4.114600E-01
Stage2-vs-Stage4
6.242600E-01
Stage3-vs-Stage4
1.817550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.477600E-01
Normal-vs-AfricanAmerican
2.009800E-01
Normal-vs-Asian
9.322400E-02
Caucasian-vs-AfricanAmerican
2.360800E-01
Caucasian-vs-Asian
2.856300E-02
AfricanAmerican-vs-Asian
5.073200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.221400E-01
Normal-vs-Female
7.606600E-01
Male-vs-Female
9.598600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.797400E-01
Normal-vs-Age(41-60Yrs)
9.757600E-01
Normal-vs-Age(61-80Yrs)
6.898000E-01
Normal-vs-Age(81-100Yrs)
3.237000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.731000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.958400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.815600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.907200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.621580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.784400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.303800E-02
Normal-vs-Daily Drinker
8.360400E-01
Normal-vs-Weekly Drinker
1.075200E-01
Normal-vs-Occasional Drinker
8.542800E-01
Normal-vs-Social Drinker
9.211800E-01
Non Drinker-vs-Daily Drinker
1.507820E-01
Non Drinker-vs-Weekly Drinker
8.968800E-01
Non Drinker-vs-Occasional Drinker
5.813800E-02
Non Drinker-vs-Social Drinker
1.462230E-01
Daily Drinker-vs-Weekly Drinker
1.641440E-01
Daily Drinker-vs-Occasional Drinker
4.669400E-01
Daily Drinker-vs-Social Drinker
5.996400E-01
Weekly Drinker-vs-Occasional Drinker
6.228400E-02
Weekly Drinker-vs-Social Drinker
1.466010E-01
Occasional Drinker-vs-Social Drinker
9.044000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.794200E-01
Normal-vs-Grade 2
1.636170E-02
Normal-vs-Grade 3
7.338500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.230500E-02
Grade 1-vs-Grade 3
6.842300E-02
Grade 1-vs-Grade 4
2.794200E-01
Grade 2-vs-Grade 3
6.065800E-01
Grade 2-vs-Grade 4
1.636170E-02
Grade 3-vs-Grade 4
7.338500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.820200E-01
Normal-vs-NonDiabetic
8.776000E-01
Diabetic-vs-NonDiabetic
2.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.855800E-02
Normal-vs-NoPancreatitis
8.326200E-01
Pancreatitis-vs-NoPancreatitis
2.915900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.653800E-01
Normal-vs-N1
3.443000E-01
N0-vs-N1
1.673630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.771440E-01
Normal-vs-TP53-NonMutant
3.575000E-01
TP53-Mutant-vs-TP53-NonMutant
1.155450E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
